The radiation dose management market size is expected to reach $1.7 billion by 2023, growing at a CAGR of 46.0% between 2017-2023. Key factors driving the market growth include increasing concerns associated with radiation overexposure, growing focus on improving quality of patient care, and growing awareness and industry initiatives.

**Browse report sample at: https://www.psmarketresearch.com/market-analysis/radiation-dose-management-market/report-sample**

Radiation dose management solutions and services are used for managing radiation dose from different imaging modalities. On the basis of modality, CT registered the largest share of the market in 2016, as it involves high doses of radiation, resulting in a marked increase in radiation exposure in the population.

Hospitals and super specialty clinics are the key end user of the radiation dose management market and held largest share in 2016, mainly due to increasing number of installation of these solutions and growing number of diagnostic procedures in the treatment and management of diseases in the hospitals.

Geographically, North America has been the largest radiation dose management market, with the U.S. being the larger contributor to the regional market, as compared to Canada. The leading position of the North American market is mainly attributable to the high number of CT examinations performed, increasing prevalence of chronic diseases and rising adoption of radiation dose management software in the region. The Medical Imaging and Technology Alliance (MITA) has taken aggressive efforts to optimize patient dose across the industry in the U.S., which is further expected to increase the demand for RDM solutions in the region.

**Explore Report at: https://www.psmarketresearch.com/market-analysis/radiation-dose-management-market**

Some of the key players operating in radiation dose management market include Bayer AG, General Electric Company, PACSHealth, LLC, Bracco Imaging S.p.A, Novarad Corporation, Siemens AG, Koninklijke Philips N.V., Sectra AB, Agfa Gevaert, and Qaleum N.V.